Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer › Research Explorer

Novosibirsk State University's Research Portal

Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer

Research output: Contribution to journal › Review article › peer-review

Structural, Functional and Comparative Genomics Laboratory

DOI

https://doi.org/10.1134/S0026893320010100
Final published version

G. Kochneva
G. F. Sivolobova
A. Tkacheva
A. A. Gorchakov
S. Kulemzin

Original language	English
Pages (from-to)	1-12
Number of pages	12
Journal	Molecular Biology
Volume	54
Issue number	1
DOIs	https://doi.org/10.1134/S0026893320010100
Publication status	Published - Jan 2020

Research areas

oncolytic viruses, chimeric antigen receptors, T-cells, NK-cells, virotherapy, anticancer immunity, cancer therapy, CHIMERIC ANTIGEN RECEPTOR, NATURAL-KILLER-CELL, MODIFIED T-CELLS, ANTITUMOR-ACTIVITY, VACCINIA VIRUS, NK CELLS, CHECKPOINT BLOCKADE, IMMUNOTHERAPY, RESPONSES, DELIVERY

OECD FOS+WOS

1.06 BIOLOGICAL SCIENCES

ID: 34670344